Investors

Events and Presentations

Analyst Coverage

Corporate Governance

Publication Archive

Investor Contacts & Alerts

News Releases

Nov 1, 2018

Evofem Biosciences to Host Key Opinion Leader Event: New Perspectives in Birth Control--Non-Hormonal, On Demand and Woman Controlled

- Currently 16.5M women in the U.S. are not using birth control and want to avoid pregnancy
Oct 24, 2018

Evofem Biosciences to Report Third Quarter 2018 Results on November 7, 2018

-- Conference Call Scheduled for 11:00 a.m. EST --
Oct 9, 2018

Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Lead Product Candidate, Amphora, and its Role as a Multipurpose Vaginal pH Regulator Presented at 2018 American Society of Reproductive Medicine Annual Congress
Oct 3, 2018

Evofem Biosciences to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora at the 2018 International Federation of Gynecology and Obstetrics (FIGO) World Congress
Sep 26, 2018

Survey Reveals High Number of Sexually Active Women Who Use No Birth Control Method, Supporting the Continued Need for Non-Hormonal Birth Control Innovations such as Evofem Biosciences' Product Candidate Amphora®

-- On World Contraception Day, these U.S statistics support the continued need for new woman-controlled, non-hormonal birth control innovations. Ideally such methods would protect against pregnancy and also have other preventive indications (such as STI prevention), thus giving women better control over their sexual and reproductive health.

Show per page